The ASCOLT trial, a landmark international Phase 3 study led by clinician-scientists in Singapore, investigated aspirin’s role in preventing colorectal cancer recurrence after surgery and chemotherapy. While the trial did not find a statistically significant improvement in disease-free survival across all patients, it revealed a consistent trend toward improved survival, especially in certain subgroups.
Keep Reading
Add A Comment